Gelofusine must not be administered in the case of: hypersensitivity towards gelatine, hypervolaemia, hyperhydration, severe cardiac insufficiency, recent event of cardiac infarction, severe disturbances of blood coagulation, severe renal insufficiency.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign Out
